Pharm-OZ SA
2.3 FTEThe score of Pharm-OZ shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +31 % Total assets +56 % Headcount (avg FTE) -30 %
Accounts of the company itself (not consolidated).
The full file covers 20 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharm-OZ's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 85,650 € | ||||
| Equity | 342,955 € | ||||
| Cash | 88,838 € | ||||
| EBITDA | 152,378 € | ||||
| Total assets | 681,585 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jul 2026
- Year ended 31 Dec 2024filed on 07 Aug 2025
- Year ended 31 Dec 2023filed on 13 Jun 2024
- Year ended 31 Dec 2022filed on 24 Mar 2023
- Year ended 31 Dec 2021filed on 07 Jul 2022
Pharm-OZ's financial analysis
- Solvency50.3%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharm-OZ
Pharm-OZ's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0401.670.169
- VAT number
- BE0401670169
- Peppol
- Registered · 0208:0401670169 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 01 Jan 1968
- Registered office
- 6060 Charleroi
- Size
- Micro · 2.3 FTE
- Latest accounts
- 2025 · filed on 09 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharm-OZ (SA) has been based in Charleroi since 1968, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 85,650 € and equity of 342,955 €; its revenue is not published. With 2.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 50.3%, above the median of its sector (41.5%).
Companies similar to Pharm-OZ
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DES Pagodes Manufacture of basic pharmaceutical products Genappe · balance sheet 383,064 €
- Blauwblomme Retail sale of pharmaceutical products Kortrijk · balance sheet 559,420 €
- Les Pharmacies Réunies Retail sale of pharmaceutical products Frameries · balance sheet 389,988 €
- Koltfarma Retail sale of pharmaceutical products Charleroi · balance sheet 488,225 €
- Apotheek Heirbaut Retail sale of pharmaceutical products Asse · balance sheet 472,369 €
- EDEHealth Services Business and other management consultancy activities Beyne-Heusay · balance sheet 23,732 €
- Boskant Retail sale of pharmaceutical products Merchtem · balance sheet 729,117 €
- Tornaphar Retail sale of pharmaceutical products Tournai · balance sheet €3.74m
Frequently asked questions about Pharm-OZ
What is the revenue of Pharm-OZ?
Pharm-OZ files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharm-OZ?
In Belgium, the VAT number is the company number prefixed with BE: BE0401670169 for Pharm-OZ, if the company is VAT-registered. Its company number (CBE) is 0401.670.169.
Where is the registered office of Pharm-OZ?
According to the CBE register, the registered office of Pharm-OZ is in 6060 Charleroi.
What is the equity of Pharm-OZ?
At the close of the 2025 financial year, the equity of Pharm-OZ amounts to 342,955 €, a solvency of 50.3% of total assets.
How many people work at Pharm-OZ?
2.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharm-OZ?
The register lists 4 active mandates at Pharm-OZ. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharm-OZ
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →